NU-DERM SYSTEM NORMAL-DRY SKIN TRANSFORMATION- hydroquinone, octinoxate, and zinc oxide kit

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Active ingredient:

Octinoxate 7.5% Zinc Oxide 10.5%

Available from:

OMP, INC.

Prescription type:

PRESCRIPTION DRUG

Therapeutic indications:

The gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. The gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. Specially formulated for blending purposes as part of the Obagi Nu-Derm System. Sunscreen - helps prevent sunburn - if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun

Authorization status:

unapproved drug other

Summary of Product characteristics

NU-DERM SYSTEM NORMAL-DRY SKIN TRANSFORMATION- HYDROQUINONE,
OCTINOXATE,
AND ZINC OXIDE
OMP, INC.
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
NU-DERM SYSTEM
NORMAL DRY
SKIN TRANSFORMATION KIT
CLEAR (SKIN BLEACHING AND CORRECTOR CREAM) NDC 62032-101-36 NET WT. 2
OZ. (57 G)
HYDROQUINONE USP, 4% RX ONLY AM+PM
Dark spots may appear on the surface of your skin, but they actually
start deep within the skin's layers.
This gentle yet effective formula absorbs into the layers of your skin
to deliver prescription-strength
hydroquinone, helping to correct the appearance of age and sun spots
for a healthier, more even
complexion.
INDICATIONS AND USAGE
The gradual bleaching of hyperpigmented skin conditions such as
chloasma, melasma, freckles, senile
lentigines, and other unwanted areas of melanin hyperpigmentation.
DOSAGE AND ADMINISTRATION
Use daily, in the morning and evening. Squeeze a small amount
(approximately 1-2 pea-size amounts)
onto your hand. Apply evenly to the entire face, extending to the
hairline, over the ears, and ending with
a feathering motion, or as directed by your physician. If no
improvement is seen after three (3) months
of treatment, use of this product should be discontinued. Sun exposure
should be limited by using a
sunscreen agent, a sun blocking agent, or protective clothing to cover
bleached skin when using and
after using this product in order to prevent darkening from
reoccurring.
WARNINGS
Avoid contact with eyes, nose, mouth, and lips. In case of accidental
contact, patient should rinse
thoroughly with water and contact a physician. Sunscreen use is an
essential aspect of hydroquinone
therapy because even minimal sunlight exposure sustains melanocytic
activity.
Contains sodium metabisulfite, a sulfite that may cause allergic-type
reactions including anaphylactic
symptoms and life-threatening or less severe asthmatic episodes in
certain suscep